We are live on ! Find out more
HA

HHLR Advisors Portfolio holdings

AUM $832M
1-Year Est. Return 32.38%
This Fund
S&P 500
This Quarter Est. Return
+31.73%
1 Year Est. Return
+32.38%
3 Year Est. Return
+137.31%
5 Year Est. Return
+86.76%
10 Year Est. Return
AUM
$4.09B
AUM Growth
+$986M
Cap. Flow
+$119M
Cap. Flow %
2.9%
Top 10 Hldgs %
93.46%
Holding
41
New
5
Increased
4
Reduced
4
Closed
8

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$280M
2
PDD icon
Pinduoduo
PDD
+$191M
3
BIDU icon
Baidu
BIDU
+$163M
4
YMM icon
Full Truck Alliance
YMM
+$50.4M
5
SE icon
Sea Limited
SE
+$30.9M

Top Sells

Rank Stock Value
1
FUTU icon
Futu Holdings
FUTU
+$178M
2
NTES icon
NetEase
NTES
+$120M
3
WNS
WNS Holdings
WNS
+$96.8M
4
JD icon
JD.com
JD
+$74.3M
5
BEKE icon
KE Holdings
BEKE
+$60.5M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 43.12%
2 Healthcare 17.5%
3 Technology 14.14%
4 Financials 13.8%
5 Communication Services 8.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PDD icon
1
Pinduoduo
PDD
$122B
$1.14B 27.76%
8,592,600
+1,615,796
+23% +$191M
BABA icon
2
Alibaba
BABA
$296B
$588M 14.37%
3,289,666
+2,139,966
+186% +$280M
FUTU icon
3
Futu Holdings
FUTU
$17.4B
$563M 13.77%
3,238,179
-1,074,058
-25% -$178M
BULL
4
Webull Corp
BULL
$4.96B
$489M 11.96%
33,080,846
ONC
5
BeOne Medicines Ltd
ONC
$41.5B
$352M 8.61%
1,034,306
BIDU icon
6
Baidu
BIDU
$32.9B
$216M 5.29%
+1,641,000
New +$163M
LEGN icon
7
Legend Biotech
LEGN
$3.87B
$195M 4.77%
5,984,550
NTES icon
8
NetEase
NTES
$78.6B
$120M 2.94%
790,807
-872,861
-52% -$120M
AVBP icon
9
ArriVent BioPharma
AVBP
$1.49B
$82.7M 2.02%
4,484,672
BEKE icon
10
KE Holdings
BEKE
$20.2B
$80.5M 1.97%
4,236,278
-3,229,187
-43% -$60.5M
YMM icon
11
Full Truck Alliance
YMM
$9.14B
$52.7M 1.29%
+4,066,553
New +$50.4M
YSG
12
Yatsen Holding
YSG
$285M
$44.3M 1.08%
4,885,873
-1,226,060
-20% -$11.7M
SE icon
13
Sea Limited
SE
$73.1B
$32.2M 0.79%
+180,050
New +$30.9M
CWAN
14
DELISTED
Clearwater Analytics
CWAN
$24.6M 0.6%
1,365,971
CTKB icon
15
Cytek Biosciences
CTKB
$608M
$23.1M 0.56%
6,657,030
NBP
16
NovaBridge Biosciences American Depositary Shares
NBP
$213M
$22.6M 0.55%
5,980,568
GOSS icon
17
Gossamer Bio
GOSS
$83.2M
$13.1M 0.32%
4,974,041
MAZE
18
Maze Therapeutics
MAZE
$1.52B
$11.9M 0.29%
457,535
API
19
Agora
API
$347M
$8.02M 0.2%
2,098,553
CTNM
20
Contineum Therapeutics
CTNM
$641M
$7.86M 0.19%
669,337
EM
21
DELISTED
Smart Share Global Ltd
EM
$5.33M 0.13%
3,949,700
SGMT icon
22
Sagimet Biosciences
SGMT
$656M
$4.97M 0.12%
724,800
TUYA
23
Tuya Inc
TUYA
$1.15B
$3.86M 0.09%
1,564,400
GE icon
24
GE Aerospace
GE
$355B
$3.02M 0.07%
10,043
+3,738
+59% +$1.02M
MOGU
25
MOGU Inc
MOGU
$15.4M
$2.91M 0.07%
847,510

Similar funds

HHLR Advisors's Q3 2025 Portfolio in Review

As of Q3 2025, HHLR Advisors held 41 positions worth $4.09B, up 32% from $3.1B the previous quarter. Its ten largest holdings account for 93% of the portfolio.

HHLR Advisors's Q3 2025 filing shows 5 new, 4 increased, 4 reduced and 8 closed positions. Its largest new stake was Baidu: 1,641,000 shares worth $216M. The largest sale was Futu Holdings, an estimated $178M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 43% of assets, up from 31% a quarter earlier, followed by Healthcare and Technology.

  • HHLR Advisors's largest Q3 2025 buy was Baidu: 1,641,000 shares worth $216M.
  • HHLR Advisors added most to Alibaba in Q3 2025, an estimated $280M increase.
  • HHLR Advisors's biggest Q3 2025 reduction was Futu Holdings, cutting an estimated $178M.
  • HHLR Advisors fully exited WNS Holdings in Q3 2025, selling an estimated $96.8M.
  • HHLR Advisors's ten largest holdings make up 93% of its $4.09B portfolio in Q3 2025.
  • HHLR Advisors opened 5 new positions and closed 8 in Q3 2025.
  • HHLR Advisors's portfolio value rose 32% quarter-over-quarter to $4.09B.

Based on HHLR Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.